Federal Trade Commission

Consumer groups want antitrust probe of hospital suppliers

BY: - November 29, 2022

The middlemen who buy things like medical equipment for hospitals have vastly consolidated their control of the marketplace in recent decades, nine consumer groups are saying.  Now the groups want the Federal Trade Commission to mount a formal investigation to see if the companies are stifling competition among medical suppliers, artificially raising costs and unnecessarily […]

Newest federal regulator wants the little guy to be the focus of antitrust enforcement

BY: - November 14, 2022

From groceries to prescriptions to paychecks, the modern American business landscape makes it increasingly difficult for poorer Americans to get what they need to survive, Alvaro Bedoya, the newest member of the Federal Trade Commission, said in an interview late last month. The consequences have taken the form of food and pharmacy "deserts" and in a paucity of jobs that pay a living wage. "I want to focus on the folks at the bottom of the ladder and are trying to move up and not fall off," he said.

Antitrust regulator takes aim at drug middlemen

BY: - September 30, 2022

The newest member of the Federal Trade Commission last week said that for decades his agency hasn’t served the historical mission of the agency — fairness. And in decrying the rise of megacorporations that dominate vast ranges of services in some economic sectors, he cited pharmacy middlemen as exhibit A. Alvaro Bedoya in May was […]

With new acquisition, CVS to get bigger and broader, raising concerns

BY: - September 14, 2022

When CVS Health announced last week that it was buying Signify Health for $8 billion, executives with both companies said it will help them to more effectively deliver care. But some observers are concerned that it means CVS and rival UnitedHealth Group are extending their dominance into yet another aspect of American health care. Dallas-based […]

Feds to probe drug rebates

BY: - June 20, 2022

The Federal Trade Commission last week announced what some observers believe could be a game-changer when it comes to the rising cost of prescription drugs. The agency — which is meant to protect fair competition — said it would look into the murky practice by which drugmakers grant rebates and other fees to insurer-owned pharmacy […]

Biden directs federal agencies to protect LGBTQI+ rights under attack in GOP-led states

BY: - June 17, 2022

President Joe Biden signed an executive order Wednesday aiming to curtail conversion therapy, expand health care access and promote safe learning for LGBTQI+ people. The order is meant to counter laws in Republican-led states that restrict the rights of LGBTQI+ kids and their families. A senior administration official referenced Texas and Florida as two states […]

Federal Trade Commission to investigate pharmacy middlemen

BY: - June 9, 2022

After years of pleading, the Federal Trade Commission on Tuesday voted to investigate the practices of some of the nation’s largest companies. They’re accused of using their dominance in myriad sectors of the health care space to drive up costs, drive out competition and reap profits. Four of the six companies to be investigated have […]

Already concerned with drug costs, large employers, family pharmacists worry about more middlemen

BY: - September 2, 2021

There already were deep concerns among small pharmacists about drug middlemen known as "pharmacy benefit managers."  Now the corporations that own them appear to be creating yet another layer of middlemen. That has even the largest employers in the country worried.

Federal regulator’s oversight of the drug supply chain blasted — by one of the regulators

BY: - June 4, 2021

One of two federal agencies tasked with policing anticompetitive behavior among corporations last week said it has a lot more work to do when it comes to the prescription-drug supply chain. One of the members of the Federal Trade Commission went even further. He suggested the agency has abdicated its responsibility as drug prices have […]

Federal probe of drug middlemen urged

BY: - May 10, 2021

After years of accusations in Ohio and elsewhere, a bipartisan group in the U.S. Senate wants federal regulators to investigate whether drug middlemen and their parent companies are rigging the system to raise prices and pad their pockets. Sens. Chuck Grassley, R-Iowa, and Maria Cantwell, D-Wash., last month filed legislation that would require the federal […]